These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35257229)

  • 1. Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections.
    Link H; Kerkmann M; Holtmann L; ;
    Support Care Cancer; 2022 Jun; 30(6):5187-5200. PubMed ID: 35257229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG testing, immunoglobulin replacement therapy, and infection outcomes in patients with CLL or NHL: real-world evidence.
    Soumerai JD; Yousif Z; Gift T; Desai R; Huynh L; Ye M; Banatwala A; Clear L; Pinaire M; Belsky G; Hsieh YG; Herrick C; Darnell EP; Duh MS; Sanchirico M; Murphy SN
    Blood Adv; 2024 Aug; 8(16):4239-4249. PubMed ID: 38904477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
    Visentin A; Molinari MC; Pravato S; Cellini A; Angotzi F; Cavaretta CA; Ruocco V; Imbergamo S; Piazza F; Proietti G; Mauro FR; Trentin L
    Curr Oncol; 2022 Dec; 30(1):274-283. PubMed ID: 36661671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen.
    Otremba B; Haslbauer F; Reiser M; Weide R; Obermeier M; Pfründer D
    Int J Clin Pharmacol Ther; 2024 Jun; 62(6):241-249. PubMed ID: 38577752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia.
    Freeman JA; Crassini KR; Best OG; Forsyth CJ; Mackinlay NJ; Han P; Stevenson W; Mulligan SP
    Leuk Lymphoma; 2013 Jan; 54(1):99-104. PubMed ID: 22738394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies.
    Na IK; Buckland M; Agostini C; Edgar JDM; Friman V; Michallet M; Sánchez-Ramón S; Scheibenbogen C; Quinti I
    Eur J Haematol; 2019 Jun; 102(6):447-456. PubMed ID: 30801785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics.
    Innocenti I; Tomasso A; Benintende G; Autore F; Fresa A; Vuono F; Stirparo L; Galli E; D'Arena G; Sorà F; Efremov D; Laurenti L
    Hematol Oncol; 2022 Aug; 40(3):469-474. PubMed ID: 35076123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiency.
    Benbrahim O; Viallard JF; Choquet S; Royer B; Bauduer F; Decaux O; Crave JC; Fardini Y; Clerson P; Lévy V
    Eur J Haematol; 2018 Jul; 101(1):48-56. PubMed ID: 29644723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypogammaglobulinemia and immunodeficiency in multiple myeloma and chronic lymphoid leukemia].
    Matthes T; Jandus P
    Rev Med Suisse; 2023 Apr; 19(821):668-673. PubMed ID: 37017348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia.
    Ohmoto A; Fuji S; Shultes KC; Savani BN; Einsele H
    Bone Marrow Transplant; 2022 Jun; 57(6):874-880. PubMed ID: 35440805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns and burden of infection in patients with chronic lymphocytic leukemia and secondary immunodeficiency: a retrospective database study.
    Siffel C; Richter J; Anderson-Smits C; Kamieniak M; Ren K; Shah D; Davids MS
    Ann Hematol; 2024 Nov; 103(11):4567-4580. PubMed ID: 39264434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary immunodeficiency in lymphoproliferative malignancies.
    Friman V; Winqvist O; Blimark C; Langerbeins P; Chapel H; Dhalla F
    Hematol Oncol; 2016 Sep; 34(3):121-32. PubMed ID: 27402426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
    Mustafa SS; Jamshed S; Vadamalai K; Ramsey A
    PLoS One; 2021; 16(10):e0258529. PubMed ID: 34653210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia.
    Spaner DE; Venema R; Huang J; Norris P; Lazarus A; Wang G; Shi Y
    EBioMedicine; 2018 Sep; 35():222-232. PubMed ID: 30174282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET).
    Syed MN; Kutac C; Miller JM; Marsh R; Sullivan KE; Cunningham-Rundles C; Fuleihan RL; Kheradmand F; Hajjar J
    J Clin Immunol; 2022 Oct; 42(7):1545-1552. PubMed ID: 35779201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study.
    Legendre P; Chahwan D; Marjanovic Z; Vignon M; Hermine O; Lortholary O; Morelle G; Darrodes M; Kahn JE; Ouzegdouh M; Chaibi P; Montestruc F; Caumont-Prim A; Le Jouan M; Hassani Y; Godeau B; Durand-Zaleski I; Mouthon L
    Clin Immunol; 2020 Jun; 215():108419. PubMed ID: 32289463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.
    Svensson T; Höglund M; Cherif H
    Scand J Infect Dis; 2013 Jul; 45(7):537-42. PubMed ID: 23427875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
    Noto A; Cassin R; Mattiello V; Bortolotti M; Reda G; Barcellini W
    Front Immunol; 2023; 14():1062376. PubMed ID: 37122737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections in secondary immunodeficiency patients treated with Privigen
    Mallick R; Divino V; Smith BD; Jolles S; DeKoven M; Vinh DC
    Leuk Lymphoma; 2021 Dec; 62(14):3463-3473. PubMed ID: 34569910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue Is Common in Immunoglobulin G Subclass Deficiency and Correlates With Inflammatory Response and Need for Immunoglobulin Replacement Therapy.
    Wågström P; Nilsdotter-Augustinsson Å; Nilsson M; Björkander J; Dahle C; Nyström S
    Front Immunol; 2021; 12():797336. PubMed ID: 35082787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.